Board Member
Erin is an innovative commercial pharma leader with demonstrated success tackling new challenges with high impact across therapeutic areas, customer segments, and geographies. She is a strategic thinker with demonstrated expertise in market access, marketing, and new product planning disciplines. Erin has a pre-pharma background includes clinical trial management, bench research, and healthcare provider practice optimization.
Sign up to hear from us about our upcoming events and projects.
Subscribe to our newsletter!
By donating to The Chrysalis Initiative, you are helping to address disparities that patients of breast cancer face while contributing to resources for these communities.
© Copyright 2023 The Chrysalis Initiative | All rights reserved. | Created By KTC ATL
